Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001869630 | SCV002248855 | uncertain significance | Early myoclonic encephalopathy | 2022-07-19 | criteria provided, single submitter | clinical testing | This variant has not been reported in the literature in individuals affected with JMJD1C-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 1334685). This variant is present in population databases (rs779931368, gnomAD 0.0009%). This sequence change replaces aspartic acid, which is acidic and polar, with tyrosine, which is neutral and polar, at codon 1667 of the JMJD1C protein (p.Asp1667Tyr). |
Greenwood Genetic Center Diagnostic Laboratories, |
RCV001814866 | SCV002061751 | uncertain significance | not provided | 2021-12-14 | no assertion criteria provided | clinical testing | Gene of uncertain significance |